Alcoholic cirrhosis and hepatocellular carcinoma

Advances in Experimental Medicine and Biology

Volumn 815, Issue , 2015, Pages 113-130

  Stickel, Felix ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Hepatology Unit Clinic Beau Site Hirslanden   (Germany)

Author keywords

Acetaldehyde; Alcohol dehydrogenase; Cytochrome P450 2E1; Gene methylation; Liver cirrhosis; Non alcoholic fatty liver disease; Retinoic acid; Viral hepatitis

Indexed keywords

ACETALDEHYDE; ALCOHOL; CARCINOGEN; REACTIVE OXYGEN METABOLITE; RETINOID;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL METABOLISM; ARTICLE; CARCINOGENICITY; CHRONIC DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DNA METHYLATION; HEPATITIS B; HEPATITIS C; HEREDITY; HOST; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MUTAGENICITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; VIRUS HEPATITIS; ANIMAL; CARCINOMA, HEPATOCELLULAR; COMPLICATION; LIVER NEOPLASMS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; OXIDATIVE STRESS;

EID: 84925326312     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-09614-8_7     Document Type: Article

References (93)

1. Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3): S206-S214.
2. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(5 Suppl 1): S35-S50.
3. McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15: 223-243.
4. WHO. Mortality database. http://www. who. int/whosis/en.
5. El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142: 1264-1273.
6. Stickel F, Schuppan D, Hahn EG, Seitz HK (2002) Cocarcinogenic effects of ethanol in hepatocarcinogenesis. Gut 51: 132-139.
7. Ascha MS, Hanouneh IA, Lopez R et al (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51: 1972-1978.
8. Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7: 599-612.
9. Baan R, Straif K, Grosse Y et al (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8: 292-293.
10. Rehm J, Klotsche J, Patra J (2007) Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res 16: 66-76.
11. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139: 817-823.
12. Parkin DM (2002) Cancer incidence in five continents, vol VIII, IARC scientific publications. IARC, Lyon.
13. El-Serag HB, Rudolph KL (2011) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
14. El-Serag HB, Mason AC (2000) Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160: 3227-3230.
15. Nzeako UC, Goodman ZD, Ishak KG (1996) Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 105: 65-75.
16. Chiesa R, Donato F, Tagger A et al (2000) Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev 9: 213-216.
17. Grando-Lemaire V, Guettier C, Chevret S et al (1999) Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 31: 508-513.
18. De Lima VM, Oliveira CP, Alves VA et al (2008) A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol 49: 1055-1061.
19. Nakanuma Y, Ohta G (1985) Is Mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis. Cancer 55: 2400-2405.
20. Smith P, Tee LBG, Yeoh GCT (1996) Appearance of oval cells in the liver of rats after longterm exposure to ethanol. Hepatology 23: 145-154.
21. Lin RS, Lee FY, Lee SD et al (1995) Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22: 165-172.
22. Yan AW, Fouts DE, Brandl J et al (2011) Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53: 96-105.
23. Tilg H, Moschen AR, Kaneider NC (2011) Pathways of liver injury in alcoholic liver disease. J Hepatol 55(5): 1159-1161.
24. Yamada Y, Kirillova I, Peschon JJ et al (1997) Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 94: 1441-1446.
25. Bharrhan S, Koul A, Chopra K, Rishi P (2011) Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One 6: e20635.
26. Stärkel P, De Saeger C, Strain AJ et al (2010) NFkappaB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease. Eur J Clin Invest 40: 575-584.
27. Qiao L, Zhang H, Yu J et al (2006) Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum Gene Ther 17: 280-290.
28. Siu L, Foont J, Wands JR (2009) Hepatitis C virus and alcohol. Semin Liver Dis 29: 188-199.
29. Kowdley KV (2004) Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127: S79-S86.
30. Marcellin P, Pequignot F, Delarocque-Astagneau E et al (2008) Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 48: 200-207.
31. Welzel TM, Graubard BI, Quraishi S et al (2013) Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol 108: 1314-1321.
32. Donato F, Tagger A, Gelatti U et al (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155: 323-331.
33. Bedogni G, Miglioli L, Masutti F et al (2008) Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study. Am J Gastroenterol 103: 2248-2253.
34. Chen CL, Yang HI, Yang WS et al (2008) Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135: 111-121.
35. Jee SH, Ohrr H, Sull JW, Samet JM (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96: 1851-1855.
36. Lambert MP, Paliwal A, Vaissière T et al (2011) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54: 705-715.
37. Miyakawa H, Izumi N, Marumo F, Sato C (1996) Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis. Alcohol Clin Exp Res 20(1 Suppl): 91A-94A.
38. Peters MG, Terrault NA (2002) Alcohol use and hepatitis C. Hepatology 36(5 Suppl 1): S220-S225.
39. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127: 1372-1380.
40. Bellentani S, Pozzato G, Saccoccio G et al (1999) Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 44: 874-880.
41. Hassan MM, Hwang LY, Hatten CJ et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36: 1206-1213.
42. Uetake S, Yamauchi M, Itoh S et al (2003) Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen-and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 27(8 Suppl): 47S-51S.
43. Donato F, Gelatti U, Limina RM, Fattovich G (2006) Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 25: 3756-3770.
44. Moriya K, Fujie H, Shintani Y et al (1998) Hepatitis C virus core protein induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1068.
45. Koike K (2007) Hepatitis C, virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol 22(Suppl 1): S108-S111.
46. Hoek JB, Pastorino JG (2004) Cellular signaling mechanisms in alcohol-induced liver damage. Semin Liver Dis 24: 257-272.
47. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997) Excess weight is a risk factor for alcoholic liver disease. Hepatology 25: 108-111.
48. Raynard B, Balian A, Fallik D et al (2002) Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35: 635-638.
49. Ekstedt M, Franzén LE, Holmqvist M et al (2009) Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 44: 366-374.
50. Dunn W, Sanyal AJ, Brunt EM et al (2012) Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol 57: 384-391.
51. Moriya A, Iwasaki Y, Ohguchi S et al (2011) Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 33: 378-388.
52. Craddock VM, Henderson AR (1991) Potent inhibition of oesophageal metabolism of N-nitrosomethylbenzylamine, an oesophageal carcinogen, by higher alcohols present in alcoholic beverages. IARC Sci Publ 564-567.
53. Kuper H, Tzonou A, Kaklamani E et al (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85: 498-502.
54. Seitz HK, Osswald B (1992) Effect of ethanol on procarcinogen activation. In: Watson R (ed) Alcohol and cancer. CRC, Boca Raton, pp 55-72.
55. Aguilar F, Hussain SP, Cerutti P (1993) Aflatoxin B1 induces the transversion of G-> T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci U S A 90: 8586-8590.
56. Bulatao-Jayme J, Almero EM, Castro MC, Jardeleza MT, Salamat LA (1982) A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 11: 112-119.
57. National Toxicology Program (2011) Acetaldehyde. Rep Carcinog 12: 21-24.
58. Helander A, Lindahl-Kiessling K (1991) Increased frequency of acetaldehyde-induced sisterchromatid exchanges in human lymphocytes treated with an aldehyde dehydrogenase inhibitor. Mutat Res 264: 103-107.
59. Maffei F, Fimognari C, Castelli E et al (2000) Increased cytogenetic damage detected by FISH analysis on micronuclei in peripheral lymphocytes from alcoholics. Mutagenesis 15: 517-523.
60. Maffei F, Forti GC, Castelli E, Stefanini GF, Mattioli S, Hrelia P (2002) Biomarkers to assess the genetic damage induced by alcohol abuse in human lymphocytes. Mutat Res 514: 49-58.
61. Matsuda T, Kawanishi M, Yagi T et al (1998) Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res 26: 1769-1774.
62. Garro AJ, Espina N, Farinati F, Salvagnini M (1986) The effects of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA. Alcohol Clin Exp Res 10: 73S-77S.
63. Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ (2005) Polyamines stimulate the formation of mutagenic 1, N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res 33: 3513-3520.
64. Fang JL, Vaca CE (1995) Development of a 32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA. Carcinogenesis 16: 2177-2185.
65. Fang JL, Vaca CE (1997) Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 18: 627-632.
66. Matsuda T, Matsumoto A, Uchida M et al (2007) Increased formation of hepatic N2-ethylidene-2′-deoxyguanosine DNA adducts in aldehyde dehydrogenase 2-knockout mice treated with ethanol. Carcinogenesis 28: 2363-2366.
67. Wang M, McIntee EJ, Cheng G, Shi Y, Villalta PW, Hecht SS (2000) Identification of DNA adducts of acetaldehyde. Chem Res Toxicol 13: 1149-1157.
68. Wang M, Yu N, Chen L, Villalta PW, Hochalter JB, Hecht SS (2006) Identification of an acetaldehyde adduct in human liver DNA and quantitation as N2-ethyldeoxyguanosine. Chem Res Toxicol 19: 319-324.
69. Stein S, Lao Y, Yang IY, Hecht SS, Moriya M (2006) Genotoxicity of acetaldehyde-and crotonaldehyde-induced 1, N2-propanodeoxyguanosine DNA adducts in human cells. Mutat Res 608: 1-7.
70. Yokoyama A, Muramatsu T, Ohmori T et al (1998) Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19: 1383-1387.
71. Homann N, Stickel F, Konig IR, Jacobs A, Junghanns K, Benesova M, Schuppan D, Himsel S, Zuber-Jerger I, Hellerbrand C, Ludwig D, Caselmann WH et al (2006) Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int J Cancer 118: 1998-2002.
72. Albano E (2002) Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic Biol Med 32: 110-114.
73. Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC (2000) Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J 14: 847-858.
74. Bautista AP (2002) Neutrophilic infiltration in alcoholic hepatitis. Alcohol 27: 17-21.
75. Chamulitrat W, Spitzer JJ (1996) Nitric oxide and liver injury in alcohol-fed rats after lipopolysaccharide administration. Alcohol Clin Exp Res 20: 1065-1070.
76. Oneta CM, Lieber CS, Li J, Ruttimann S, Schmid B, Lattmann J, Rosman AS, Seitz HK (2002) Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36: 47-52.
77. Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, Fu P, Fang C, Ingelman-Sundberg M, Donohue TM Jr, French SW (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224: 302-308.
78. Bradford BU, Kono H, Isayama F et al (2005) Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41: 336-344.
79. Morgan K, French SW, Morgan TR (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36: 122-134.
80. Frank A, Seitz HK, Bartsch H, Frank N, Nair J (2004) Immunohistochemical detection of 1, N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis. Carcinogenesis 25: 1027-1031.
81. Fernando RC, Nair J, Barbin A, Miller JA, Bartsch H (1996) Detection of 1, N6-ethenodeoxyadenosine and 3, N4-ethenodeoxycytidine by immunoaffinity/32 P-postlabelling in liver and lung DNA of mice treated with ethyl carbamate (urethane) or its metabolites. Carcinogenesis 17: 1711-1718.
82. Wang Y, Millonig G, Nair J et al (2009) Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 50: 453-461.
83. Nair J, Srivatanakul P, Haas C, Jedpiyawongse A, Khuhaprema T, Seitz HK, Bartsch H (2010) High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancerprone liver diseases. Mutat Res 683: 23-28.
84. Mandrekar P (2011) Epigenetic regulation in alcoholic liver disease. World J Gastroenterol 17: 2456-2464.
85. Stickel F, Herold C, Seitz HK, Schuppan D (2006) Alcohol and methyl transfer: Implication for alcohol related hepatocarcinogenesis. In: Ali S, Friedman SL, Mann DA (eds) Liver disease: biochemical mechanisms and new therapeutic insights. Science Publisher Enfield, Plymouth, pp 45-58.
86. Leo MA, Lieber CS (1982) Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 307: 597-601.
87. Wang XD, Liu C, Chung J et al (1998) Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver. Hepatology 28: 744-750.
88. Liu C, Russell RM, Seitz HK, Wang XD (2001) Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 120: 179-189.
89. Dan Z, Popov Y, Patsenker E, Preimel D, Liu C, Wang XD, Seitz HK, Schuppan D, Stickel F (2005) Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J 19: 845-847.
90. Albanes D, Heinonen OP, Taylor PR et al (1996) Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88: 1560-1570.
91. Nahon P, Sutton A, Rufat P et al (2009) Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 50: 1484-1493.
92. Stickel F, Hampe J (2012) Genetic determinants of alcoholic liver disease. Gut 61: 150-159.
93. Trépo E, Nahon P, Bontempi G et al (2014) Association between the PNPLA3 (rs738409 C > G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology 59(6): 2170-2177. doi: 10. 1002/hep. 26767.